Theravance Inc (NASDAQ:THRX)

16.65
Delayed Data
As of May 22
 +0.34 / +2.08%
Today’s Change
10.58
Today|||52-Week Range
31.80
+17.67%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Glaxosmithkline Plc
Buy8/11/2014172,651$22.13$3.8M-24.76%
Glaxosmithkline Plc
Buy3/02/201592,674$19.22$1.8M-13.37%
Glaxosmithkline Plc
Buy5/11/201585,579$16.00$1.4M+3.42%
Lee Junning
Senior Vice President-Technical Operations
Sale8/13/201453,424$22.50$1.2M-26.43%
Shafer Bradford J
General Counsel & Senior Vice President
Sale8/11/201427,108$22.12$599.6K-24.76%
Shafer Bradford J
General Counsel & Senior Vice President
Buy8/11/201433,667$14.53$489.2K-24.76%
Lee Junning
Senior Vice President-Technical Operations
Buy8/13/201424,338$12.66$308.1K-26.43%
Lee Junning
Senior Vice President-Technical Operations
Buy8/13/201423,705$12.66$300.1K-26.43%
Lee Junning
Senior Vice President-Technical Operations
Buy8/13/201412,516$14.53$181.9K-26.43%
Lee Junning
Senior Vice President-Technical Operations
Buy8/13/201413,882$9.81$136.2K-26.43%
Page of 6

To view my watchlist

Not a member yet?

Sign up now for a free account